Southern Association for Vascular Surgery
SAVS Home SAVS Home Past & Future Meetings Past & Future Meetings

Back to 2023 Abstracts


Long-term (>10 years) Durability and Clinical Outcome Comparing CEA with ACUSEAL (PTFE) Patching vs Pericardial Patching; Results from a Prospective Randomized Trail
Zachary AbuRahma1, Elizabeth Williams2, Andrew Lee2, Ali F AbuRahma1, Meghan Davis-Jordan1, Christina Veith2, Noah Dargy2, Scott Dean3, Elaine Davis3
1Robert C. Byrd Health Sciences Center of W. Va. Univ., Charleston, WV;2Charleston Area Medical Center, Charleston, WV;3CAMC Institute of Academic Medicine, Charleston, WV

Background/PurposeSeveral studies have shown the superiority of CEA with patch closure over primary closure. However, no definite study has shown any significant differences in clinical outcome between various types of patches. Since more vascular surgeons are utilizing pericardial patching recently, this study will analyze late clinical outcome (≥10-years) of our previously reported prospective randomized trial comparing CEA with ACUSEAL (PTFE) vs pericardial patching.Patient Population/Methods 200 CEAs were randomized (1:1) to either VASCU Guard pericardial patching or ACUSEAL patching. All patients had immediate duplex ultrasound which was repeated at six months and annually thereafter. Kaplan-Meier analysis was used to estimate rates of freedom from stroke, stroke free survival, and rates of freedom from ≥50% and ≥80% restenosis.ResultsOverall demographic and clinical characteristics were somewhat similar with a mean follow up of 80 months (range of 0-149 months). Rates of freedom from stroke were 97, 97, 97, 96, 93 for ACUSEAL vs 99, 98, 97, 97, 92, for pericardial patching (p=0.1112) at 1, 2, 3, 5 and 10 years respectively (Fig 1). Similarly, the rates of freedom from stroke/death were 94, 93, 90, 76, 50 for ACUSEAL vs 99, 96, 91, 78, 47 for pericardial patching (p=0.8591). Rates of freedom from ≥50% restenosis were 98, 98, 96, 89, 79, for ACUSEAL vs 87, 83, 83, 81, 71 for pericardial patching (p=0.0489) (Fig 2). Rates of freedom from ≥80% restenosis were 99, 99, 99, 96, 85, for ACUSEAL vs 96, 96, 96, 93, 93 for pericardial patching (p=0.9407). The overall survival rates were 95, 94, 91, 77, 51 for ACUSEAL vs 100, 98, 93, 79, 50 for pericardial patching (p=0.9123).Other patch complications (e.g., rupture, aneurysmal dilation, infection, etc.) were similar. Conclusion
Both CEA with ACUSEAL (PTFE) and pericardial patching are durable and have similar clinical outcomes at 10 years except ACUSEAL patching has significantly better rates of freedom from ≥50% restenosis.


Back to 2023 Abstracts